| References |
1. In vitro anticancer potentiality and molecular modelling study of novel amino acid derivatives based on N1,N3-bis-(1-hydrazinyl-1-oxopropan-2-yl) isophthalamide Asmaa F. Kassem, Gaber O. Moustafa, Eman S. Nossier, Hemat S. Khalaf, Marwa M. Mounier, Suliman A. Al-Yousef, Sabry Y. Mahmoud J Enzyme Inhib Med Chem. 2019; 34(1): 1247–1258. Published online 2019 Jul 9. doi: 10.1080/14756366.2019.1613390 PMCID: PMC6691786 2. Amelioration of Acute Mercury Toxicity by a Novel, Non-Toxic Lipid Soluble Chelator N,N′bis-(2-mercaptoethyl)isophthalamide: Effect on Animal Survival, Health, Mercury Excretion and Organ Accumulation David Clarke, Roger Buchanan, Niladri Gupta, Boyd Haley Toxicol Environ Chem. Author manuscript; available in PMC 2012 May 7.Published in final edited form as: Toxicol Environ Chem. 2012; 94(3): 616–640. doi: 10.1080/02772248.2012.657199 PMCID: PMC3346673 3. Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex Arun K. Ghosh, Margherita Brindisi, Prasanth R. Nyalapatla, Jun Takayama, Jean-Rene Ella-Menye, Sofiya Yashchuk, Johnson Agniswamy, Yuan-Fang Wang, Manabu Aoki, Masayuki Amano, Irene T. Weber, Hiroaki Mitsuya Bioorg Med Chem. Author manuscript; available in PMC 2018 Oct 1.Published in final edited form as: Bioorg Med Chem. 2017 Oct 1; 25(19): 5114–5127. Published online 2017 Apr 9. doi: 10.1016/j.bmc.2017.04.005 PMCID: PMC5617771 4. Binding of group 15 and group 16 oxides by a concave host containing an isophthalamide unit Jens Eckelmann, Vittorio Saggiomo, Svenja Fischmann, Ulrich Lüning Beilstein J Org Chem. 2012; 8: 11–17. Published online 2012 Jan 3. doi: 10.3762/bjoc.8.2 PMCID: PMC3302070 |
